(MUD fMRI) Phase I Study of the Safety and Feasibility of Psilocybin in Adults with Methamphetamine Use Disorder

The PI of this project is:

This project is funded by: Industry Sponsored - Revive Therapeutics

The term of this project is: March 2022 to December 2040

The number of subjects scanned during this project is: 12